This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Disgusting Reaction to Ebola Patient's Death by Tekmira, Chimerix Traders

10/08/14 - 11:33 AM EDT

Tekmira shares surge after Thomas Duncan's death announced.

READ FULL POST

Arrowhead Research Sinks on Disappointing Hepatitis B Drug Data

10/08/14 - 10:38 AM EDT

In an ongoing phase II study, ARC-520 dosed at 2 mg/kg induced a 0.3 log reduction in HBsAG, a measure of the presence of hepatitis B virus in the body.

READ FULL POST

It's True, Small-Cap Biotech Stocks Are Acting Badly These Days

10/07/14 - 11:39 AM EDT

For the past three months, small-cap biotech stocks have been underperforming the broader market.

READ FULL POST

Shkreli's Inability to Focus, Immaturity Cost Him Retrophin CEO Job

09/30/14 - 05:53 PM EDT

Martin is super smart and will be a great asset somewhere, but he is not a CEO. I wish him the best.

READ FULL POST

Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax

09/30/14 - 09:49 AM EDT

What are the motivations behind significant takeovers, like J&J's takeover of Alios Biopharma? And why have companies like Achillion and Novavax been passed over?

READ FULL POST

Clovis Shares Higher on Improved Outlook for Lung Cancer Drug

09/29/14 - 12:17 PM EDT

Clovis Oncology shares are higher Monday because AstraZeneca, its direct competitor to develop a new, genetically targeted lung cancer drug, slipped this weekend.

READ FULL POST

Gilead Sciences' Next-Generation HIV Drug Hits the Mark

09/24/14 - 10:30 AM EDT

TAF is an improved version of Gilead's stalwart but patent challenged HIV drug Viread.

READ FULL POST

Merrimack Does Well to License Marginal Cancer Drug to Baxter

09/24/14 - 08:14 AM EDT

Baxter has a hunger for cancer drugs with hair.

READ FULL POST

Tekmira Experimental Ebola Drug Used to Treat Stricken U.S. Doctor

09/22/14 - 07:48 PM EDT

Ebola patient Dr. Rick Sacra received treatment with Tekmira Pharmaceuticals' experimental ebola therapy TKM-Ebola for seven days, Nebraska Medical Center confirmed.

READ FULL POST

Northwest Bio's Almost-Toxic Debt Raise Responsible for Stock Slide

09/22/14 - 08:59 AM EDT

The buyers of Northwest's debt want the stock price to decline before Feb. 15, 2015, because a lower stock price also will drop the conversion price of the notes.

READ FULL POST

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs